BioSpace News Archive

Browse BioSpace’s published news and press releases by year, month, and day.
72 Results
Year
Month
Day
  • HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has entered into a definitive securities purchase agreement to sell securities in a private placement with a leading healthcare investor.
  • The Company entered into an amended Share Purchase Agreement with Add Biomedical to acquire the Target shares for a revised purchase price of CAD $3.3 million (the “Purchase Price”).